iNtRON Biotechnology Inc
KOSDAQ:048530
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
iNtRON Biotechnology Inc
Other Non-Cash Items
iNtRON Biotechnology Inc
Other Non-Cash Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Non-Cash Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
i
|
iNtRON Biotechnology Inc
KOSDAQ:048530
|
Other Non-Cash Items
₩1.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
129%
|
CAGR 10-Years
1%
|
|
|
Celltrion Inc
KRX:068270
|
Other Non-Cash Items
₩265.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Other Non-Cash Items
-₩9.8B
|
CAGR 3-Years
-72%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Other Non-Cash Items
-₩2.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Other Non-Cash Items
-₩20.2B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-47%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Other Non-Cash Items
₩2.5B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
iNtRON Biotechnology Inc
Glance View
iNtRON Biotechnology, Inc. is a Korea-based company principally engaged in the biotechnology industry. The Company operates its business through two main divisions: genetic reagent division and molecular diagnostics division. Its genetic reagent division is involved in the research and development of reagents, which are under the brand names of Maxime and pLUG for life science research. Its molecular diagnostics division is engaged in the development and production of nucleic acid tester for infectious diseases. It also engages in the operation of veterinary antibiotic alternative business and new biopharmaceuticals development business. The Company distributes its products within domestic market and to overseas markets.
See Also
What is iNtRON Biotechnology Inc's Other Non-Cash Items?
Other Non-Cash Items
1.3B
KRW
Based on the financial report for Dec 31, 2025, iNtRON Biotechnology Inc's Other Non-Cash Items amounts to 1.3B KRW.
What is iNtRON Biotechnology Inc's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 10Y
1%
